![]() ![]() That study assessed the experience of patients during the first 11 months after introduction of the new tablets. In May another group of researchers reported a similar decline based on 11 months of data from patients in 324 drug treatment centers throughout the United States. “What they didn’t take into account was that the pill was pretty easy to crush,” allowing addicts to snort or inject it to get an immediate rush, Cicero told Reuters Health. “We should have asked the question, ‘If they stop using the most popular drug out there, what are they going to turn to now?’”Ĭicero said that when the drug first came out, Ox圜ontin “was advertised by the company and the Food and Drug Administration (FDA) as having a very low abuse potential” because of the slow-release formula. Louis, lead author of the letter detailing the results. They turned to something else,” said Theodore Cicero of Washington University in St. That jump accounted for nearly all of the increase in the use of opioids other than Ox圜ontin, including high-potency fentanyl and hydromorphone. In the same time period, heroin use doubled among those surveyed. In recent interviews, only about 13 percent of addicts with an opioid dependence said Ox圜ontin was their primary drug of abuse, compared to about 36 percent before the new version of the prescription tablet became available. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |